Genetic Signatures Limited (GSS.AX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. John R. Melki BSc, Ph.D. | MD, CEO & Executive Director | 470.64k | -- | -- |
| Mr. Michael Anton Aicher BSc, M.B.A., MBA | Executive Director of US Operations & Executive Director | 178.42k | -- | 1960 |
| Mr. Christopher M. Abbott | Founder & Chairman Emeritus | -- | -- | -- |
| Mr. Karl David Pechmann | CFO, COO & Company Secretary | -- | -- | -- |
| Dr. Douglas S. Millar BSc, Ph.D. | Chief Scientific Officer | 289.09k | -- | -- |
| Ms. Rebecca Abbatantuono | Global Head of People & Culture | -- | -- | -- |
| Ms. Neralie Coulston B.Sc. | Global Head of Regulatory Affairs | -- | -- | -- |
| Mr. Jackson Jones B.Sc. | Chief Commercial Officer | -- | -- | -- |
Genetic Signatures Limited
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.
Corporate Governance
Recent Events
Recent Events Information Not Available